Larisa Reyderman

USPTO Granted Patents = 6 (Patent Applications = 5)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 54(Granted Patents)

Company Filing History:

Eisai R&d Management Co., Ltd.

where one patent can have more than one assignee

Years Active: 2009-2023

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11642347 - EZH2 inhibitors for treating lymphoma (2023-05-09),

2. 10166238 - EZH2 inhibitors for treating lymphoma (2019-01-01),

3. 9345692 - Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxy-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same (2016-05-24),

4. 8404702 - Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same (2013-03-26),

5. 7981905 - Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same (2011-07-19),

6. 7563801 - Pharmaceutical formulations: salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same (2009-07-21),

Title: Larisa Reyderman: Innovator in Cancer Treatment

Introduction

Larisa Reyderman, based in Watchung, NJ, is an accomplished inventor with a proven track record of innovation in the field of cancer treatment. With six patents to her name, her work is contributing significantly to advancements in therapeutic approaches against lymphoma.

Latest Patents

Among her notable contributions are her latest patents for EZH2 inhibitors. These patents describe compositions comprising inhibitors of human histone methyltransferase EZH2, which are pivotal for the treatment of cancer, particularly lymphoma. Her inventions are set to improve patient outcomes and offer new avenues for cancer therapy.

Career Highlights

Throughout her career, Larisa has made significant strides while working with prominent companies such as Opko Health, Inc. and Epizyme, Inc. Her expertise in biochemistry and molecular biology has propelled her into the forefront of medical innovation, leading to groundbreaking research in cancer therapeutics.

Collaborations

Larisa has collaborated with talented colleagues like Zhihui Qiu and Heike Keilhack. These collaborations have facilitated a fruitful exchange of ideas and expertise, further enhancing the impact of her work in the scientific community.

Conclusion

Larisa Reyderman is a remarkable inventor whose contributions to the field of cancer research are commendable. Her dedication to developing effective treatments showcases the vital role of innovation in healthcare, and her patents stand as a testament to her commitment to fighting cancer. As the landscape of medical science evolves, her work will undoubtedly play a crucial role in shaping the future of cancer therapies.

This text is generated by artificial intelligence and may not be accurate.